Thieno[2,3-d]pyrimidine-2,4-diones
US6300334A · kind A · utility
4Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 13, 1999 |
| Grant date | Oct 9, 2001 |
| Priority date | — |
| Expiry date | Oct 13, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I): ##STR1## PA1 wherein R.sup.1, R.sup.2, and R.sup.3 are defined in the specification. The compounds are useful for treating or reducing the risk of reversible obstructive airways disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.